SEC Form D private-offering filing

Qlaris Bio, Inc.

Name: Qlaris Bio, Inc. - new SEC Form D private-offering filing, Dedham, MA
Published: 2026-06-17

A new SEC Form D private-offering notice from Dedham, MA, a $3,946,659 filer-stated offering target in Biotech. The source filing is one click away.

Qlaris Bio, Inc. site↗ Verified via SEC Form D

Clinical-stage biotechnology company developing first-in-class therapies for glaucoma and other ophthalmic conditions.

Filed 2026-06-17Filed to raise $3,946,659First money in 2026-06-12Raised so far $3,946,659HQ (as filed) Dedham, MASector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified qlaris.bio↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.